Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
91 studies found for:    Narcolepsy
Show Display Options
Rank Status Study
21 Completed Efficacy and Safety Study of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy
Conditions: Narcolepsy;   Excessive Daytime Sleepiness;   Cataplexy;   Sleep Disorders
Interventions: Drug: BF2.649;   Drug: Modafinil;   Drug: Placebo
22 Completed
Has Results
Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness
Conditions: Excessive Daytime Sleepiness;   Narcolepsy;   Obstructive Sleep Apnea/Hypopnea Syndrome;   Chronic Shift Work Sleep Disorder
Intervention: Drug: Armodafinil 100 to 250 mg/day
23 Recruiting Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in Narcolepsy
Conditions: Narcolepsy;   Excessive Sleepiness
Interventions: Drug: JZP-110;   Drug: Placebo
24 Not yet recruiting Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy
Conditions: Excessive Daytime Sleepiness;   Cataplexy;   Narcolepsy
Interventions: Drug: Sodium Oxybate;   Drug: Placebo
25 Recruiting A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2
Conditions: Idiopathic Hypersomnia;   Narcolepsy Without Cataplexy
Interventions: Drug: BTD-001;   Drug: Placebo
26 Enrolling by invitation "A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA"
Conditions: Narcolepsy;   Obstructive Sleep Apnea
Intervention: Drug: JZP-110
27 Completed Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients
Condition: Narcolepsy
Intervention: Drug: sodium oxybate
28 Recruiting Sleep and Memory in Children
Conditions: Sleep Apnea;   Temporo-central Epilepsy;   Narcolepsy;   High Intellectual Potential;   Healthy Subject
Interventions: Other: memory evaluation at V1 and V2 (with treatment);   Other: memory evaluation at V1 (without treatment);   Other: memory evaluation at V1 and V2 (without treatment)
29 Active, not recruiting A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy
Condition: Narcolepsy With Cataplexy
Intervention: Drug: Xyrem
30 Completed
Has Results
Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome
Conditions: Excessive Daytime Sleepiness;   Narcolepsy;   Obstructive Sleep Apnea/Hypopnea Syndrome (OSAHS)
Intervention: Drug: Armodafinil
31 Completed A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness
Condition: Narcolepsy
Interventions: Drug: ADX-N05;   Drug: Placebo
32 Unknown  Narcolepsy - New Potential Treatment
Condition: Narcolepsy
Interventions: Device: Kinetic Oscillation Stimulation Device;   Device: Kinetic Oscillation Stimulation Device in placebo mode
33 Completed Provigil (Modafinil) Study by Taiwan Biotech Co.
Conditions: Narcolepsy;   Cataplexy;   Sleep Disorders;   Hypersomnolence;   Excessive Sleepiness
Intervention: Drug: Modafinil
34 Completed Efficacy and Safety Study of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With Narcolespy
Conditions: Narcolepsy;   Cataplexy;   Excessive Daytime Sleepiness
Interventions: Drug: BF2.649;   Drug: BF2.649 add on Modafinil
35 Completed Assess the Safety and Effectiveness of PROVIGIL Treatment in Children and Adolescents With Excessive Sleepiness
Condition: Narcolepsy
Intervention: Drug: Modafinil
36 Unknown  Effect of Intranasal Administration of Orexine A on IL-6-System, Sleep-Wake-Regulation and Neurocognition
Condition: Narcolepsy
Intervention: Drug: Orexine A
37 Completed
Has Results
Clarithromycin for the Treatment of Hypersomnia
Conditions: Hypersomnia;   Idiopathic Hypersomnia;   Narcolepsy
Interventions: Drug: Clarithromycin followed by placebo;   Drug: Placebo then Clarithromycin
38 Completed
Has Results
Flumazenil for the Treatment of Primary Hypersomnia
Conditions: Hypersomnia;   Primary Hypersomnia;   Idiopathic Hypersomnia;   Narcolepsy Without Cataplexy
Intervention: Drug: Flumazenil
39 Recruiting Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Followed by a Prolonged Open-label Period
Conditions: Narcolepsy With Cataplexy;   Narcolepsy Without Cataplexy
Interventions: Drug: pitolisant;   Drug: Placebo
40 Recruiting Neurophysiologic Correlates of Hypersomnia
Conditions: Major Depressive Disorder;   Primary Hypersomnia;   Bipolar Disorder;   Narcolepsy;   Primary Insomnia
Intervention: Other: Acoustical slow wave induction

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years